Publication | Closed Access

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma

MedicineBioanalysisAntiviral Drug DevelopmentAntiviral TherapyVirologyHuman PlasmaUplc-ms/ms Bioanalytical MethodChronic Viral InfectionClinical ChemistryHivAntiviral DrugPharmacologyAntiviral CompoundSimultaneous QuantificationDrug Analysis